Literature DB >> 19189342

Concentration dependent dual effect of thrombin in endothelial cells via Par-1 and Pi3 Kinase.

Jong-Sup Bae1, Yong-Ung Kim, Moon-Ki Park, Alireza R Rezaie.   

Abstract

Disruption of endothelial barrier is a critical pathophysiological factor in inflammation. Thrombin exerts a variety of cellular effects including inflammation and apoptosis through activation of the protease activated receptors (PARs). The activation of PAR-1 by thrombin is known to have a bimodal effect in endothelial cell permeability with a low concentration (pM levels) eliciting a barrier protective and a high concentration (nM levels) eliciting a barrier disruptive response. It is not known whether this PAR-1-dependent activity of thrombin is a unique phenomenon specific for the in vitro assay or it is part of a general anti-inflammatory effect of low concentrations of thrombin that may have a physiological relevance. Here, we report that low concentrations of thrombin or of PAR-1 agonist peptide induced significant anti-inflammatory activities. However, relatively high concentration of thrombin or of PAR-1 agonist peptide showed pro-inflammatory activities. By using function-blocking anti-PAR-1 antibodies and PI3 kinase inhibitor, we show that the direct anti-inflammatory effects of low concentrations of thrombin are dependent on the activation of PAR-1 and PI3 kinase. These results suggest a role for cross communication between PAR-1 activation and PI3 kinase pathway in mediating the cytoprotective effects of low concentrations of thrombin in the cytokine-stimulated endothelial cells. J. Cell. Physiol. 219: 744-751, 2009. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19189342      PMCID: PMC2663600          DOI: 10.1002/jcp.21718

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  59 in total

1.  Pro- and anti-inflammatory actions of thrombin: a distinct role for proteinase-activated receptor-1 (PAR1).

Authors:  N Vergnolle; M D Hollenberg; J L Wallace
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

2.  Thrombin-induced interleukin-8 production and its regulation by interferon-gamma and prostaglandin E2 in human monocytic U937 cells.

Authors:  K Suk; S Cha
Journal:  Immunol Lett       Date:  1999-04-15       Impact factor: 3.685

3.  Proteinase-activated receptor-2 in human skin: tissue distribution and activation of keratinocytes by mast cell tryptase.

Authors:  M Steinhoff; C U Corvera; M S Thoma; W Kong; B E McAlpine; G H Caughey; J C Ansel; N W Bunnett
Journal:  Exp Dermatol       Date:  1999-08       Impact factor: 3.960

4.  The requirement of both intracellular reactive oxygen species and intracellular calcium elevation for the induction of heparin-binding EGF-like growth factor in vascular endothelial cells and smooth muscle cells.

Authors:  Y Kayanoki; S Higashiyama; K Suzuki; M Asahi; S Kawata; Y Matsuzawa; N Taniguchi
Journal:  Biochem Biophys Res Commun       Date:  1999-05-27       Impact factor: 3.575

5.  Interactions of mast cell tryptase with thrombin receptors and PAR-2.

Authors:  M Molino; E S Barnathan; R Numerof; J Clark; M Dreyer; A Cumashi; J A Hoxie; N Schechter; M Woolkalis; L F Brass
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

7.  A dual thrombin receptor system for platelet activation.

Authors:  M L Kahn; Y W Zheng; W Huang; V Bigornia; D Zeng; S Moff; R V Farese; C Tam; S R Coughlin
Journal:  Nature       Date:  1998-08-13       Impact factor: 49.962

8.  Cloning and characterization of human protease-activated receptor 4.

Authors:  W F Xu; H Andersen; T E Whitmore; S R Presnell; D P Yee; A Ching; T Gilbert; E W Davie; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1998-06-09       Impact factor: 11.205

9.  Thrombin-activated human endothelial cells support monocyte adhesion in vitro following expression of intercellular adhesion molecule-1 (ICAM-1; CD54) and vascular cell adhesion molecule-1 (VCAM-1; CD106).

Authors:  G Kaplanski; V Marin; M Fabrigoule; V Boulay; A M Benoliel; P Bongrand; S Kaplanski; C Farnarier
Journal:  Blood       Date:  1998-08-15       Impact factor: 22.113

10.  Thrombin-induced DNA synthesis of cultured human dental pulp cells is dependent on its proteolytic activity and modulated by prostaglandin E2.

Authors:  M C Chang; C P Lin; T F Huang; W H Lan; Y L Lin; C C Hsieh; J H Jeng
Journal:  J Endod       Date:  1998-11       Impact factor: 4.171

View more
  32 in total

1.  Thrombin down-regulates the TGF-beta-mediated synthesis of collagen and fibronectin by human proximal tubule epithelial cells through the EPCR-dependent activation of PAR-1.

Authors:  Jong-Sup Bae; In-San Kim; Alireza R Rezaie
Journal:  J Cell Physiol       Date:  2010-10       Impact factor: 6.384

2.  Thrombin upregulates the angiopoietin-Tie2 Axis: endothelial protein C receptor occupancy prevents the thrombin mobilization of angiopoietin 2 and P-selectin from Weibel-Palade bodies.

Authors:  J-S Bae; A R Rezaie
Journal:  J Thromb Haemost       Date:  2010-02-17       Impact factor: 5.824

3.  Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.

Authors:  Ruchika Sharma; Amanda P Waller; Shipra Agrawal; Katelyn J Wolfgang; Hiep Luu; Khurrum Shahzad; Berend Isermann; William E Smoyer; Marvin T Nieman; Bryce A Kerlin
Journal:  J Am Soc Nephrol       Date:  2017-04-19       Impact factor: 10.121

4.  Paradoxical bleeding and thrombotic episodes of dysprothrombinaemia due to a homozygous Arg382His mutation.

Authors:  Qiulan Ding; Likui Yang; Xiaoqing Zhao; Wenman Wu; Xuefeng Wang; Alireza R Rezaie
Journal:  Thromb Haemost       Date:  2016-12-15       Impact factor: 5.249

5.  Barrier protective effects of lycopene in human endothelial cells.

Authors:  Jae Woan Bae; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2011-04-13       Impact factor: 4.575

6.  Polyphosphate suppresses complement via the terminal pathway.

Authors:  Jovian M Wat; Jonathan H Foley; Michael J Krisinger; Linnette Mae Ocariza; Victor Lei; Gregory A Wasney; Emilie Lameignere; Natalie C Strynadka; Stephanie A Smith; James H Morrissey; Edward M Conway
Journal:  Blood       Date:  2013-12-13       Impact factor: 22.113

7.  Anti-inflammatory effects of kaempferol-3-O-sophoroside in human endothelial cells.

Authors:  Tae Hoon Kim; Sae-Kwang Ku; In-Chul Lee; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2011-11-24       Impact factor: 4.575

8.  Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro.

Authors:  Dong-Chan Kim; Wonhwa Lee; Jong-Sup Bae
Journal:  Inflamm Res       Date:  2011-09-16       Impact factor: 4.575

9.  Occupancy of human EPCR by protein C induces β-arrestin-2 biased PAR1 signaling by both APC and thrombin.

Authors:  Ram Vinod Roy; Abdolreza Ardeshirylajimi; Peyman Dinarvand; Likui Yang; Alireza R Rezaie
Journal:  Blood       Date:  2016-08-25       Impact factor: 22.113

10.  Unexpected anti-hypertrophic responses to low-level stimulation of protease-activated receptors in adult rat cardiomyocytes.

Authors:  Anke C Fender; Goran Pavic; Grant R Drummond; Gregory J Dusting; Rebecca H Ritchie
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-08-01       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.